|
Sign In to gain access to subscriptions and/or personal tools.
|
Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project
Stephen R Wisniewski
Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, 127 Parran Hall, 130 Desoto Street, Pittsburgh, PA 15261, USA wisniew{at}edc.pitt.edu
Heather Eng
Leslie Meloro
Robert Gatt
University of Pittsburgh, Pittsburgh, PA, USA
Louise Ritz
National Institute of Mental Health, Bethesda, MD, USA
Diane Stegman
Madhukar Trivedi
Melanie M Biggs
Edward Friedman
Kathy Shores-Wilson
Diane Warden
University of Texas Southwestern Medical Center, Dallas, TX, USA
Douglas Bartolowits
Jeffrey P Martin
University of Pittsburgh, Pittsburgh, PA, USA
A John Rush
University of Texas Southwestern Medical Center, Dallas, TX, USA
While efficient methods of communication are known to be essential in conducting large multicenter clinical trials, very little information is provided on actual methods that can be implemented to improve communication. An integrated technology-based communication system was developed for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project, which prospectively defines treatments that are most effective for participants with a diagnosis of a nonpsychotic major depressive disorder (MDD) who report an unsatisfactory clinical outcome to an initial and, if necessary, subsequent treatment(s). This web-based communication system is comprised of a multi-faceted study Web site, including a help desk, document sharing, a project directory and reports. In addition, automated reporting via e-mail and an online data correction mechanism are also available. The STARD communication system improves communication between study personnel and improves the quality of the study's data through the integration of system elements, the integration of those elements with traditional forms of communication, by filling the gaps not addressed by those traditional methods and by reducing the staff workload burden.
Clinical Trials, Vol. 1, No. 4,
387-398 (2004)
DOI: 10.1191/1740774504cn035oa

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Rush, S. R. Wisniewski, D. Warden, J. F. Luther, L. L. Davis, M. Fava, A. A. Nierenberg, and M. H. Trivedi
Selecting Among Second-Step Antidepressant Medication Monotherapies: Predictive Value of Clinical, Demographic, or First-Step Treatment Features
Arch Gen Psychiatry,
August 1, 2008;
65(8):
870 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Thase, E. S. Friedman, M. M. Biggs, S. R. Wisniewski, M. H. Trivedi, J. F. Luther, M. Fava, A. A. Nierenberg, P. J. McGrath, D. Warden, et al.
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
Focus,
January 1, 2008;
6(1):
104 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Warden, M. H. Trivedi, S. R. Wisniewski, L. Davis, A. A. Nierenberg, B. N. Gaynes, S. Zisook, S. D. Hollon, G.K. Balasubramani, R. Howland, et al.
Predictors of Attrition During Initial (Citalopram) Treatment for Depression: A STAR*D Report
Am J Psychiatry,
August 1, 2007;
164(8):
1189 - 1197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Thase, E. S. Friedman, M. M. Biggs, S. R. Wisniewski, M. H. Trivedi, J. F. Luther, M. Fava, A. A. Nierenberg, P. J. McGrath, D. Warden, et al.
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
Am J Psychiatry,
May 1, 2007;
164(5):
739 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Nierenberg, M. Fava, M. H. Trivedi, S. R. Wisniewski, M. E. Thase, P. J. McGrath, J. E. Alpert, D. Warden, J. F. Luther, G. Niederehe, et al.
A Comparison of Lithium and T3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report
Am J Psychiatry,
September 1, 2006;
163(9):
1519 - 1530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. McGrath, J. W. Stewart, M. Fava, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, M. E. Thase, L. Davis, M. M. Biggs, K. Shores-Wilson, et al.
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report
Am J Psychiatry,
September 1, 2006;
163(9):
1531 - 1541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fava, A. J. Rush, S. R. Wisniewski, A. A. Nierenberg, J. E. Alpert, P. J. McGrath, M. E. Thase, D. Warden, M. Biggs, J. F. Luther, et al.
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
Am J Psychiatry,
July 1, 2006;
163(7):
1161 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mitchell, M. Shah, S. Ahmad, A. S. Rogers, J. H Ellenberg, and Adolescent Medicine Trials Network for HIV/AIDS In
A unified web-based Query and Notification System (QNS) for subject management, adverse events, regulatory, and IRB components of clinical trials
Clinical Trials,
February 1, 2005;
2(1):
61 - 71.
[Abstract]
[PDF]
|
 |
|
|
|